Non-psychotic uses for anti-psychotics

Journal of Drugs in Dermatology, March-April, 2004 by Aparche Yang, John Y. Koo

References

1. Koo, JY. Psychodermatolgy: A Practical Manual for Clinicians. Current Problems in Dermatology 1995; pg 204-232.

2. Gupta MA, Gupta AK. Psychodermtology: An Update. J Am Acad Dermatol 1996; 34: 1030-5.

3. FDA. http://www.fda.gov/

4. PDR. http://pdr.net/

5. FDA. http://www.fda.gov/oc/ohrt/irbs/offlabel.html

6. Tarascon. Pocket Pharmacopoeia 2003 Deluxe Lab-coat Pocket Edition: p. 238.

7. Tarascon. Pocket Pharmacopoeia 2003 Deluxe Lab-coat Pocket Edition: p. 237.

8. Kaplan and Sadock. Comprehensive Textbook of Psychiatry 1995; 2:1987-2003.

9. Gelder, Lopex-Ibor, Andreasen. New Oxford Text of Psychiatry 2000; 2:1314-25.

10. Rosencheck R, Leslie D, Sernyak M. From clinical trial to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veteran Affairs. Med Care 2001; 39(3):302-8.

11. Weiss E, Hummer M, Koller D, Pharmd, Ulmer H. Fleischhacker WW. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 2000; 20(6):695-8.

12. Lieberman JA. The Use of Antipsychotics in Primary Care. Printary Care. Companion J Clin Psychiatry 2003; 5(suppl3):3-8.

13. Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manage 2003; 25(3):288-91.

14. Smith PF, Corelli RL. Doxepin in the management of pruritus associated with allergic cutaneous reactions. Ann Pharmacother 1997; 31(5):633-5.

15. Koblenzer CS. Treatment of "cutaneous self-injurious behavior" (CSIB). Int J Dermatol 1998; 37(8):633-4.

16. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989; 155:686-91.

17. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997; 19(1):29-35.

18. Tabarrok, A. Assessing the FDA via the Anomaly of Off-Label Drug Prescribing. The Independent Review 2000; 5(1):25-53.

19. Tsuneizumi T, et al. Effects of bromocriptine in Huntington chorea. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18(4):823-9.

20. Jimenez-Jimenez FJ, Garcia-Ruiz PJ. Pharmacological options for the treatment of Tourette's disorder. Drugs 2001; 61(15):2207-20.

21. Tishler PV. The effect of therapeutic drugs and other pharmacologic agents on activity of porphobilinogen deaminase, the enzyme that is deficient in intermittent acute porphyria. Life Sci 1999; 65(2):207-14.

22. Mendels J, et al. Effective short-term treatment of generalized anxiety disorder with trifluoperazine. J Clin Psychiatry 1986; 47(4):170-4.

APARCHE YANG BS (1), JOHN Y KOO MD (2)

1 GRADUATING STUDENT PHYSICIAN, UNIVERSITY OF CALIFORNIA, IRVINE

2 PROFESSOR, UNIVERSITY OF CALIFORNIA, SAN FRANCISO, DEPARTMENT OF DERMATOLOGY DIRECTOR, UCSF PSORIASIS AND SKIN TREATMENT CENTER AND PHOTOTHERAPY UNIT

ADDRESS FOR CORRESPONDENCE:

Aparche Yang BS

Graduating Student Physician

University of California. Irvine

1334 Verano Place

Irvine, CA 92612

Phone: 949-697-7806

E-mail: yangap@mail.nih.gov